Takamizawa A, Matsumoto S, Iwata T, Tochino Y, Katagiri K, Yamaguchi K
J Med Chem. 1975 Apr;18(4):376-83. doi: 10.1021/jm00238a011.
A synthetic study was made on the active metabolite of cyclophosphamide. Ozonolysis of O-(3 butenyl)-N,N-bis(2-chloroethyl)phosphorodiamidate, prepared by reaction of POC13 with 3-buten-1-ol followed by treatment with N,N-bis(2-chloroethyl)amine (nor mustard) and NH3, afforded 2-[bis(2-chloroethyl)amino]-4-hydroperoxytetrahydro-2H-1, 3,2-oxazaphosphorine 2-oxide (4-hydroperoxycyclophosphamide). Deoxygenation of 4-hydroperoxycyclophosphamide by triphenylphosphine yielded 4-hydroxycyclophosphamide in a pure crystalline state. These products exhibited high cytostatic activity in both in vitro and in vivo experiments. The results give confirmatory evidence for the hypothesis that C4-hydroxylation on the 1,3,2-oxazaphosphorinane ring of cyclophosphamide is necessary for its activation.
对环磷酰胺的活性代谢产物进行了合成研究。通过使三氯氧磷与3-丁烯-1-醇反应,然后用N,N-双(2-氯乙基)胺(去甲氮芥)和氨处理制备的O-(3-丁烯基)-N,N-双(2-氯乙基)磷酰胺的臭氧分解反应得到2-[双(2-氯乙基)氨基]-4-氢过氧四氢-2H-1,3,2-恶唑磷杂环-2-氧化物(4-氢过氧环磷酰胺)。三苯基膦将4-氢过氧环磷酰胺脱氧得到纯结晶态的4-羟基环磷酰胺。这些产物在体外和体内实验中均表现出高细胞抑制活性。这些结果为环磷酰胺1,3,2-恶唑磷杂环戊烷环上的C4-羟基化对其活化是必需的这一假设提供了确凿证据。